Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Psychiatry"
DOI: 10.3389/fpsyt.2022.822976
Abstract: Background Selective serotonin reuptake inhibitors (SSRIs) are the first-line pharmacotherapy for obsessive-compulsive disorder (OCD), but a large proportion of patients do not achieve remission after an adequate SSRI trial. To the best of our knowledge,…
read more here.
Keywords:
treatment ocd;
pharmacotherapy;
trial;
pharmacotherapy options ... See more keywords